Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

2.

Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K.

Oncogene. 2003 Oct 23;22(48):7600-6.

PMID:
14576822
3.

The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.

Neubauer BL, McNulty AM, Chedid M, Chen K, Goode RL, Johnson MA, Jones CD, Krishnan V, Lynch R, Osborne HE, Graff JR.

Cancer Res. 2003 Sep 15;63(18):6056-62.

4.

Antisense and RNAi: powerful tools in drug target discovery and validation.

Lavery KS, King TH.

Curr Opin Drug Discov Devel. 2003 Jul;6(4):561-9. Review.

PMID:
12951819
5.

Antisense oligonucleotide therapy in cancer.

Stephens AC, Rivers RP.

Curr Opin Mol Ther. 2003 Apr;5(2):118-22. Review.

PMID:
12772500
6.

Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis.

Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, Mäkelä S, Warner M, Gustafsson JA.

Proc Natl Acad Sci U S A. 2003 May 27;100(11):6694-9. Epub 2003 May 9. Erratum in: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8298.

7.

DNA methylation as a cancer-specific biomarker: from molecules to populations.

Patel A, Groopman JD, Umar A.

Ann N Y Acad Sci. 2003 Mar;983:286-97. Review.

PMID:
12724233
8.

A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

Yao X, Hu JF, Daniels M, Shiran H, Zhou X, Yan H, Lu H, Zeng Z, Wang Q, Li T, Hoffman AR.

J Clin Invest. 2003 Jan;111(2):265-73.

9.

DNA hypermethylation: when tumour suppressor genes go silent.

Garinis GA, Patrinos GP, Spanakis NE, Menounos PG.

Hum Genet. 2002 Aug;111(2):115-27. Epub 2002 Jul 16. Review.

PMID:
12189484
10.

Estrogen receptor beta in the prostate.

Weihua Z, Warner M, Gustafsson JA.

Mol Cell Endocrinol. 2002 Jul 31;193(1-2):1-5. Review. No abstract available.

PMID:
12160995
11.

Gene silencing in mammalian cells and the spread of DNA methylation.

Turker MS.

Oncogene. 2002 Aug 12;21(35):5388-93. Review.

12.

DNA methylation analysis in mammalian cells.

Clark SJ, Warnecke PM.

Methods. 2002 Jun;27(2):99-100. No abstract available.

PMID:
12095265
13.

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.

Kim HT, Kim BC, Kim IY, Mamura M, Seong DH, Jang JJ, Kim SJ.

J Biol Chem. 2002 Sep 6;277(36):32510-5. Epub 2002 Jun 25.

14.

Induction of UDP-glucuronosyltransferase 1A8 mRNA by 3-methylcholanthene in rat hepatoma cells.

Leung YK, Ho JW.

Biochem Pharmacol. 2002 Feb 15;63(4):767-75.

PMID:
11992647
15.

CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.

Nojima D, Li LC, Dharia A, Perinchery G, Ribeiro-Filho L, Yen TS, Dahiya R.

Cancer. 2001 Oct 15;92(8):2076-83.

PMID:
11596023
16.

The multiple untranslated first exons system of the human estrogen receptor beta (ER beta) gene.

Hirata S, Shoda T, Kato J, Hoshi K.

J Steroid Biochem Mol Biol. 2001 Jul;78(1):33-40.

PMID:
11530282
17.

Frequent loss of estrogen receptor-beta expression in prostate cancer.

Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.

Cancer Res. 2001 Jul 15;61(14):5331-5.

18.
19.

Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

Signoretti S, Loda M.

Am J Pathol. 2001 Jul;159(1):13-6. Review. No abstract available.

20.

DNA methylation, chromatin inheritance, and cancer.

Rountree MR, Bachman KE, Herman JG, Baylin SB.

Oncogene. 2001 May 28;20(24):3156-65. Review.

Supplemental Content

Support Center